Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Branislav Jeremic

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Hepato-Gastroenterology|March 24, 2005
Dose escalation of concurrent hypofractionated radiotherapy and continuous infusion 5-FU-chemotherapy in advanced adenocarcinoma of the pancreasFrank B Zimmermann, Branislav Jeremic, Christian Lersch, et al.
Frontiers in Oncology|August 30, 2017
Radiation Therapy in Extensive Stage Small Cell Lung CancerBranislav Jeremic, Antonio Gomez-Caamano, Pavol Dubinsky, et al.
International Journal of Radiation Oncology, Biology, Physics|February 2, 2011
Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy AgencyYasushi Nagata, Joern Wulf, Ingmar Lax, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II studyBranislav Jeremic, Biljana Milicic, Danica Grujicic, et al.
Lung Cancer (Amsterdam, Netherlands)|February 15, 2002
No thoracic radiation myelitis after spinal cord dose > or = 50.4 Gy using 1.2. Gy b.i.d. fractionation in patients with Stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapyBranislav Jeremic, Yuta Shibamoto, Biljana Milicic, et al.
Radiation Oncology (London, England)|November 28, 2019
Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY) clonogenic cells in unresectable bulky non-small cell lung cancer: profound non-targeted effects by sparing peri-tumoral immune microenvironmentSlavisa Tubin, Mohammad K Khan, Gerardo Salerno, et al.
Expert Review of Anticancer Therapy|October 16, 2009
Radiochemotherapy in small-cell lung cancerLucyna Kepka, Arkadiusz Sprawka, Francesc Casas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 24, 2007
Lung cancer management in limited resource settings: guidelines for appropriate good careFergus R Macbeth, Raymond P Abratt, Kwan H Cho, et al.
Expert Review of Anticancer Therapy|October 16, 2009
Combination of radiotherapy and chemotherapy in locally advanced NSCLCLucyna Kepka, Arkadiusz Sprawka, Francesc Casas, et al.
Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancerFrank B Zimmermann, Hans Geinitz, Sabine Schill, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Hepato-Gastroenterology|March 24, 2005
Dose escalation of concurrent hypofractionated radiotherapy and continuous infusion 5-FU-chemotherapy in advanced adenocarcinoma of the pancreasFrank B Zimmermann, Branislav Jeremic, Christian Lersch, et al.
Frontiers in Oncology|August 30, 2017
Radiation Therapy in Extensive Stage Small Cell Lung CancerBranislav Jeremic, Antonio Gomez-Caamano, Pavol Dubinsky, et al.
International Journal of Radiation Oncology, Biology, Physics|February 2, 2011
Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy AgencyYasushi Nagata, Joern Wulf, Ingmar Lax, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II studyBranislav Jeremic, Biljana Milicic, Danica Grujicic, et al.
Lung Cancer (Amsterdam, Netherlands)|February 15, 2002
No thoracic radiation myelitis after spinal cord dose > or = 50.4 Gy using 1.2. Gy b.i.d. fractionation in patients with Stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapyBranislav Jeremic, Yuta Shibamoto, Biljana Milicic, et al.
Radiation Oncology (London, England)|November 28, 2019
Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY) clonogenic cells in unresectable bulky non-small cell lung cancer: profound non-targeted effects by sparing peri-tumoral immune microenvironmentSlavisa Tubin, Mohammad K Khan, Gerardo Salerno, et al.
Expert Review of Anticancer Therapy|October 16, 2009
Radiochemotherapy in small-cell lung cancerLucyna Kepka, Arkadiusz Sprawka, Francesc Casas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 24, 2007
Lung cancer management in limited resource settings: guidelines for appropriate good careFergus R Macbeth, Raymond P Abratt, Kwan H Cho, et al.
Expert Review of Anticancer Therapy|October 16, 2009
Combination of radiotherapy and chemotherapy in locally advanced NSCLCLucyna Kepka, Arkadiusz Sprawka, Francesc Casas, et al.
Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancerFrank B Zimmermann, Hans Geinitz, Sabine Schill, et al.
Pageof 9